Bone marrow-derived adult mesenchymal stem cells for treatment of type I diabetes

The aim of this study is to determine the safety and efficacy of treatment of newly diagnosed type 1 diabetic patients with allogeneic bone marrow-derived mesenchymal stem cells (MSCs). MSCs from a 1st degree relative will be administered.